---
document_datetime: 2025-05-02 15:43:22
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/alprolix-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: alprolix-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.2527316
conversion_datetime: 2025-12-22 10:50:11.254824
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Alprolix

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, please also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Variation type IB /  | C. SAFETY, EFFICACY, | 30/04/2025                          |                                             | SmPC and PL                      |           |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000262414                        | PHARMACOVIGILANCE CHANGES - C.z Other variation - Accepted C.I.z - To update sections 2 and 4.4 in SmPC and section 2 in Package Leaflet following the excipients with known effect guideline, where the wording for Polysorbate was added. The MAH took the opportunity to update the PI due to an inconsistency which was detected in the text for instructional video. As a consequence, section 6.6 of the SmPC and section \"Instructions for Preparation and Administration\" in the Package Leaflet were updated. Finally, minor linguistic corrections were applied in all the   |            |     |
|------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IA_IN / EMA/VR/0000263807 | B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.a Secondary packaging site - Accepted                                                                                                                                                                                                                                                                                                                                                                                                         | 08/04/2025 | N/A |